Standard Chem & Pharm CO., LTD.
TWSE:1720.TW
63.6 (TWD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,239.768 | 5,851.368 | 4,604.082 | 4,305.4 | 3,937.129 | 3,573.093 | 3,848.684 | 3,673.801 | 3,321.366 | 3,295.656 | 3,053.983 | 3,373.811 | 3,332.008 | 2,894.482 | 2,284.616 | 2,182.198 | 2,011.721 | 1,924.414 |
| Cost of Revenue
| 3,514.39 | 3,363.755 | 2,536.209 | 2,385.562 | 2,227.998 | 2,028.483 | 2,099.686 | 2,097.542 | 1,826.285 | 1,847.958 | 1,756.385 | 2,058.985 | 1,999.757 | 1,664.48 | 1,235.437 | 1,119.196 | 984.172 | 913.224 |
| Gross Profit
| 2,725.378 | 2,487.613 | 2,067.873 | 1,919.838 | 1,709.131 | 1,544.61 | 1,748.998 | 1,576.259 | 1,495.081 | 1,447.698 | 1,297.598 | 1,314.826 | 1,332.251 | 1,230.002 | 1,049.179 | 1,063.002 | 1,027.549 | 1,011.19 |
| Gross Profit Ratio
| 0.437 | 0.425 | 0.449 | 0.446 | 0.434 | 0.432 | 0.454 | 0.429 | 0.45 | 0.439 | 0.425 | 0.39 | 0.4 | 0.425 | 0.459 | 0.487 | 0.511 | 0.525 |
| Reseach & Development Expenses
| 266.272 | 251.878 | 241.788 | 227.211 | 225.765 | 224.918 | 239.633 | 241.116 | 238.982 | 242.77 | 226.429 | 204.746 | 175.707 | 137.94 | 147.417 | 148.623 | 149.574 | 130.309 |
| General & Administrative Expenses
| 414.102 | 353.329 | 272.547 | 283.997 | 283.246 | 295.427 | 324.675 | 275.828 | 253.343 | 288.219 | 295.311 | 263.324 | 237.64 | 221.91 | 133.914 | 133.448 | 141.466 | 112.142 |
| Selling & Marketing Expenses
| 794.519 | 746.173 | 675.925 | 708.48 | 690.312 | 625.483 | 643.215 | 641.179 | 619.271 | 539.385 | 510.667 | 632.185 | 711.447 | 546.812 | 465.184 | 448.404 | 427.371 | 411.647 |
| SG&A
| 1,199.573 | 1,099.502 | 948.472 | 992.477 | 973.558 | 920.91 | 967.89 | 917.007 | 872.614 | 827.604 | 805.978 | 895.509 | 949.087 | 768.722 | 599.098 | 581.852 | 568.837 | 523.789 |
| Other Expenses
| -0.019 | 209.327 | 146.228 | 59.662 | 78.685 | 141.606 | 21.766 | 78.272 | 117.748 | 92.784 | 110.168 | 71.007 | 96.215 | 39.731 | 20.198 | 10.733 | 13.96 | 25.001 |
| Operating Expenses
| 1,465.826 | 1,351.38 | 1,190.26 | 1,219.688 | 1,199.323 | 1,145.828 | 1,207.523 | 1,158.123 | 1,111.596 | 1,070.374 | 1,032.407 | 1,100.255 | 1,124.794 | 906.662 | 746.515 | 730.475 | 718.411 | 654.098 |
| Operating Income
| 1,259.552 | 1,436.52 | 1,021.931 | 774.062 | 590.244 | 398.782 | 541.475 | 418.136 | 383.485 | 377.324 | 265.191 | 214.571 | 207.457 | 323.34 | 302.664 | 332.527 | 309.138 | 357.092 |
| Operating Income Ratio
| 0.202 | 0.246 | 0.222 | 0.18 | 0.15 | 0.112 | 0.141 | 0.114 | 0.115 | 0.114 | 0.087 | 0.064 | 0.062 | 0.112 | 0.132 | 0.152 | 0.154 | 0.186 |
| Total Other Income Expenses Net
| 178.315 | -36.587 | -8.181 | -1.135 | -4.434 | 118.684 | 8.737 | 43.619 | 80.217 | 81.27 | 103.728 | 99.844 | 111.18 | 33.265 | 14.351 | 15.011 | 31.023 | 28.788 |
| Income Before Tax
| 1,437.867 | 1,399.933 | 1,013.75 | 772.927 | 585.81 | 517.466 | 550.212 | 461.755 | 463.702 | 458.594 | 368.919 | 314.415 | 318.637 | 356.605 | 317.015 | 347.538 | 340.161 | 385.88 |
| Income Before Tax Ratio
| 0.23 | 0.239 | 0.22 | 0.18 | 0.149 | 0.145 | 0.143 | 0.126 | 0.14 | 0.139 | 0.121 | 0.093 | 0.096 | 0.123 | 0.139 | 0.159 | 0.169 | 0.201 |
| Income Tax Expense
| 279.938 | 246.313 | 176.948 | 147.367 | 115.377 | 89.53 | 116.873 | 89.947 | 95.803 | 74.864 | 63.57 | 45.354 | 66.904 | 80.454 | 24.198 | 79.421 | 79.711 | 70.648 |
| Net Income
| 834.886 | 1,153.62 | 706.734 | 524.172 | 376.482 | 374.359 | 363.286 | 340.216 | 347.894 | 374.235 | 298.386 | 271.426 | 246.748 | 210.053 | 293.463 | 274.597 | 267.715 | 323.443 |
| Net Income Ratio
| 0.134 | 0.197 | 0.154 | 0.122 | 0.096 | 0.105 | 0.094 | 0.093 | 0.105 | 0.114 | 0.098 | 0.08 | 0.074 | 0.073 | 0.128 | 0.126 | 0.133 | 0.168 |
| EPS
| 4.67 | 6.46 | 3.96 | 2.93 | 2.11 | 2.09 | 2.03 | 1.9 | 1.95 | 2.09 | 1.73 | 1.64 | 1.47 | 1.26 | 1.76 | 1.64 | 1.61 | 1.95 |
| EPS Diluted
| 4.67 | 6.45 | 3.95 | 2.93 | 2.11 | 2.09 | 2.03 | 1.9 | 1.95 | 2.09 | 1.71 | 1.59 | 1.41 | 1.22 | 1.75 | 1.64 | 1.61 | 1.95 |
| EBITDA
| 1,578.976 | 1,735.125 | 1,242.995 | 1,007.848 | 804.368 | 734.929 | 749.878 | 656.98 | 632.825 | 617.509 | 519.77 | 431.593 | 470.889 | 471.488 | 415.661 | 444.503 | 429.136 | 472.014 |
| EBITDA Ratio
| 0.253 | 0.297 | 0.27 | 0.234 | 0.204 | 0.206 | 0.195 | 0.179 | 0.191 | 0.187 | 0.17 | 0.128 | 0.141 | 0.163 | 0.182 | 0.204 | 0.213 | 0.245 |